Management and outcomes of advanced hemangioendothelioma at a medical oncology clinic in an Indian tertiary care center.

We recognize an aggressive subset of HEs with manifestations such as acute liver failure and splenic rupture. Currently no biomarkers predict the efficacy of TKIs over chemotherapy; however, TKIs showed promising outcomes in this series.